MedPath

QUALAQUIN

These highlights do not include all the information needed to use QUALAQUIN safely and effectively. See full prescribing information for QUALAQUIN. QUALAQUIN (quinine sulfate) Capsules, USP for Oral useInitial U.S. Approval: 2005 BOXED WARNING (See full prescribing information for complete boxed warning)

Approved
Approval ID

ce2ffee3-3048-43a0-ac45-ee32ce0c4c33

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 18, 2010

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

QUININE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-595
Application NumberNDA021799
Product Classification
M
Marketing Category
C73594
G
Generic Name
QUININE SULFATE
Product Specifications
Route of AdministrationORAL
Effective DateMarch 18, 2010
FDA Product Classification

INGREDIENTS (1)

QUININE SULFATEActive
Quantity: 324 mg in 1 1
Code: KF7Z0E0Q2B
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

QUALAQUIN - FDA Drug Approval Details